Social injustice killing people on a grand scale reports WHO's Commission bi13511681 A child born a Glasgow, Scotland suburb can expect a life 28 years shorter than another living only 13 kilometres away. A girl Lesotho likely to live 42 years less than another Japan. In Sweden, the risk of a woman dying during pregnancy and childbirth 1 17 400; Afghanistan, the odds are 1 8. Biology does not explain any of this. Instead, the differences between - and ..

Clinical Data Receives Lilly Global Supplier Award (Business Wire via Yahoo! bi13511681 NEWTON, Mass.---- Data, Inc. announced today that Cogenics® division, the global leader outsourced genomics services, has been recognized by Eli Lilly and Company for offering value-based genomics solutions that enable Lilly to create and sustain a competitive advantage

Bilcare GCS Expands Phase III Clinical Trial Service Capabilities (Marketwire bi13511681 As part of commitment to providing customers comprehensive services that span the entire supply chain, Bilcare Global Supplies, a leading single-source provider of trial supplies and services, has enhanced global Phase III capabilities. Its latest Phase III investments include the upgrade of Kalish large-scale bottling line at U.S. facility ..

Report Provides An Extensive Overview Of Clinical Research Outsourcing And Ro bi13511681 Research and Markets has announced the addition of the " Research Outsourcing Where are We?" report to offering

Agile Therapeutics Achieves Phase 2 Study Endpoints In Key Clinical Trials Wi bi13511681 Agile Therapeutics, Inc., announced that successfully completed two key trials the development of the company's new, innovative low-dose, once-weekly, contraceptive patch, the company refers to by internal product code AG-200-15. The Phase 2b safety and efficacy study successfully met primary endpoint of ovulation suppression, cycle control and safety

Phase III Clinical Studies Of Aclidinium Bromide Show Statistical Significanc bi13511681 Forest Laboratories, Inc. (NYSE: FRX) and Laboratorios Almirall, S.A. announced results from two global Phase III studies of aclidinium bromide, a novel long-acting inhaled anticholinergic for the treatment of patients chronic obstructive pulmonary disease (COPD)

Clinical Resource Network Named to 2008 Inc. 5000 List (Business Wire via Yah bi13511681 DEERFIELD, Ill.----Inc. announced placed Resource Network 2674th on 2008 annual ranking of the 5,000 fastest-growing private companies the country and the Top 100 businesses the greater Chicagoland area on August 20, 2008

MAP Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplug bi13511681 MAP Pharmaceuticals, Inc. today announced that the Company present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008, at 10:20 am New York City

Cougar Biotechnology to Present at Morgan Stanley Global Healthcare Conferenc bi13511681 LOS ANGELES----Cougar Biotechnology, Inc. today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, at 9:10 a.m

Spheris Releases Clarity(TM) Cornerstone for Clinical Documentation (Centre D bi13511681 Spheris has released the latest version of Clarity(TM) Cornerstone platform for medical language specialists, blending back-end speech understanding by M*Modal Spheris' innovative workflow management solutions to offer advanced documentation

ATEL Ventures Portfolio Company, Adenosine Therapeutics to be Acquired by Cli bi13511681 ATEL Ventures, a leading provider of secured financing to emerging growth companies, pleased to announce that Data, Inc. has entered an agreement to acquire Adenosine Therapeutics, an ATEL portfolio company. Data (Nasdaq:CLDA) paid $11 million cash, and entered a $22 million, five-year promissory note and a separate $3.2 million, 32-month promissory note to ..

Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint o bi13511681 Alexza Pharmaceuticals, Inc. today announced positive results from first Phase 3 trial of AZ-004 schizophrenic patients acute agitation

Does treatment of depression improve prognosis after heart attack? (News-Medi bi13511681 Depression and heart disease are the two leading disorders the strongest contributions to the global burden of disease. Depression and heart disease are also intertwined

Honda Aero Accessories - Home